About NF-kappa-B inhibitor beta
NF-kappa-B inhibitor beta (NFKBIB) is a protein
from Homo sapiens identified by UniProt accession
Q15653, 356 residues long.
MolForge cross-references it against 0 known binders and
121 disease associations.
Target properties
| Protein name | NF-kappa-B inhibitor beta |
| UniProt accession | Q15653 |
| Gene | NFKBIB |
| Organism | Homo sapiens |
| Length | 356 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (121)
Diseases linked to this target (Open Targets).
- serum gamma-glutamyl transferase measurement · score 0.14
- body height · score 0.11
- gastrointestinal stromal tumor · score 0.07
- common variable immunodeficiency · score 0.05
- isolated agammaglobulinemia · score 0.05
- Sepsis · score 0.05
- immunodeficiency 18 · score 0.04
- combined immunodeficiency with skin granulomas · score 0.04
- polyarticular juvenile idiopathic arthritis, rheumatoid factor positive · score 0.04
- immunodeficiency 99 with hypogammaglobulinemia and autoimmune cytopenias · score 0.04
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q15653-F1 | alphafold | PREDICTED | 76.36 | — |
Amino-acid sequence (356 residues)
MAGVACLGKA ADADEWCDSG LGSLGPDAAA PGGPGLGAEL GPGLSWAPLV FGYVTEDGDT ALHLAVIHQH EPFLDFLLGF SAGTEYMDLQ NDLGQTALHL AAILGETSTV EKLYAAGAGL CVAERRGHTA LHLACRVGAH ACARALLQPR PRRPREAPDT YLAQGPDRTP DTNHTPVALY PDSDLEKEEE ESEEDWKLQL EAENYEGHTP LHVAVIHKDV EMVRLLRDAG ADLDKPEPTC GRSPLHLAVE AQAADVLELL LRAGANPAAR MYGGRTPLGS AMLRPNPILA RLLRAHGAPE PEGEDEKSGP CSSSSDSDSG DEGDEYDDIV VHSSRSQTRL PPTPASKPLP DDPRPV
Explore NF-kappa-B inhibitor beta with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets